MedTrace Logo

Efficacy of the "Start to Move" Protocol on Functionality, Delirium and Acquired Weakness in ICU

NCT05053724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2021-09-22

No results posted yet for this study

Summary

Background: ICU hospitalization is associated with loss of strength, functionality and delirium. The "Start to Move protocol" demonstrated efficacy in improving and minimizing such effects.

Aim: To evaluate the effectiveness of the "Start to move protocol" compared with conventional treatment in ICU subjects on functionality, weakness acquired in the Intensive Care Unit (ICU-AW), incidence of delirium, days of invasive mechanical ventilation (IMV), ICU stay and 28-day mortality.

Methods: Randomized controlled clinical trial. Including adults ≥15 years with IMV \>48 hours, randomized into Start to move and conventional treatment groups.Functionality, ICU-AW incidence, delirium incidence, IMV days, ICU stay and mortality-28 days were analyzed.

Conditions

  • Intensive Care Unit Acquired Weakness
  • Intensive Care Unit Delirium
  • Intensive Care Neuropathy
  • Intensive Care Unit Syndrome
  • Mechanical Ventilation Complication

Interventions

OTHER

Star to move Protocol

Progressive physical therapy according to the Gosslink protocol called "Start to move".

Sponsors & Collaborators

  • Hospital Felix Bulnes

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-07-10
Completion
2019-11-30

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05053724 on ClinicalTrials.gov